Figure 5 | Scientific Reports

Figure 5

From: A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma

Figure 5

Construction of the prognostic risk model. The distribution plots of risk scores of ESCC patients in the (A) training, (B) validation, and (C) all cohorts. (D–F) Heatmap showing the expression profiles of the eight FMGs of ESCC patients in training, (B) validation, and (C) all cohorts. ESCC esophageal squamous cell carcinoma, FMGs fatty acid metabolism-related genes.

Back to article page